Sigmoid Pharma, Pharmascience deal

Sigmoid granted Pharmascience's Pendopharm division exclusive rights to commercialize CyCol in Canada. Pendopharm invested EUR5 million ($6.4 million) in Sigmoid, which will also receive an undisclos...